FASN and neurodegenerative disease: Additionally, investigations into the interplay between HSV-1 and host lipid metabolism in more complex in vivo models—especially those relevant to neurodegenerative diseases—will be crucial for advancing this field and assessing the translational potential of FASN inhibitors.